Bosch Health Campus Logo Bosch Health Campus Logo
Home
Team
Prof. Dr. Markus Ketteler
Chief Physician General Internal Medicine and Nephrology; Research Group Leader Peritoneum & Drug Response

Prof. Markus Ketteler


Tel +49-711-8101 3496

Major Projects

  • Biobank “Peritonealdialyse) S569-PD, RBK
  • Peritoneal membrane integrity
  • Identification of deliverable drugs for treatment of PD patients in clinical practice
  • Establishment of a directional peritoneal model

Selected References

Ketteler M, Wiecek A, Rosenkranz AR, Ose C, Rekowski J, Lorenz H, Hellmann B, Karus M, Ruhmann M, Ammer R. Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase III randomised controlled NOPHOS trial. Nephrol Dial Transplant. 2022 Jun 25:gfac206.
Oberacker T, Fritz P, Schanz M, Alscher MD, Ketteler M, Schricker S. Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis. Antioxidants (Basel) . 2022 Jun 6;11(6):1124.
Schricker S, Oberacker T, Fritz P, Ketteler M, Alscher MD, Schanz M. Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis Patients. Kidney Blood Press Res. 2022;47(2):125-134.
Ketteler M, Wiecek A, Rosenkranz AR, Pasch A, Rekowski J, Hellmann B, Karus M, Ammer R. Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial. Kidney Int Rep. 2021 Dec 19;6(3):594-604.
Neri L, Kreuzberg U, Bellocchio F, Brancaccio D, Barbieri C, Canaud B, Stuard S, Ketteler M. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study. Nephrol Dial Transplant. 2019 Apr 1;34(4):682-691.

Education and Professional Career

2019 - present

Department Head of General Internal Medicine and Nephrology / Geriatrics at the Robert-Bosch-Krankenhaus Stuttgart, Germany

2007 – 2019

Division Chief of Nephrology, Klinikum Coburg, and Head of KfH-Nierenzentrum Coburg, Germany

2000 – 2007

Assistant Professor, Consultant (Nephrology/Internal Medicine) at the Department of Nephrology and Clinical Immunology, University Hospital Aachen, Germany

1994 – 2000

Residency/Clinical Fellowship at the Department of Endocrinology, Nephrology and Rheumatology, University Hospital Benjamin Franklin, Charité Berlin, Germany

1992 – 1994

Post-Doctoral Fellowship (DFG) at the Division of Nephrology, University of Utah Health Sciences Center, Utah, USA

1989 – 1992

Internship and Residency at the Department of Nephrology and Hypertension, University Hospital Steglitz, Free University Berlin, Germany

1989

    M.D. degree, University of Heidelberg, Germany

Professional Memberships

  • American Society of Nephrology (ASN)
  • International Society of Nephrology (ISN)
  • European Renal Association (ERA)
  • German Society of Nephrology (DGfN)
  • German Transplantation Society (DTG)
  • Council Member of the ERA 2009 – 2018, Congress President of the Annual ERA Congress 2021 in Berlin
  • Co-Chair of the KDIGO CKD-MBD Guideline Update 2015 – 2017
  • Board member of the Kidney Health Initiative (KHI) of the American Society of Nephrology (ASN) from 2017 – 2019
  • Board of Directors of the „Kuratorium für Dialyse und Nierentransplantation“ (KfH e.V.) 2020 – 2026
  • Executive Committee of the KDIGO Guideline Initiative 2020 - 2022

Scientific Journal Editorial Board Memberships

  • Nephrology, Dialysis & Transplantation (Theme Editor)
  • Clincal Nephrology
  • Journal of Nephrology

Research Group

Peritoneum & Drug Response